Group 1 - The demand for antiviral drugs has significantly increased due to a rise in flu patients across multiple regions in the country [1] - Sales of various antiviral medications, including Oseltamivir and Mabalaosavir, have surged, with Oseltamivir's sales increasing by 237% and Mabalaosavir's by 180% in the past week [3] - Other medications such as antipyretics, cough suppressants, and nasal sprays have also seen sales increases exceeding 53% [3] Group 2 - In northern cities like Shenyang, Changchun, Xi'an, and Hohhot, the sales of specific flu medications have grown by over 1.5 times [5] - Flu test kits have experienced a tenfold increase in cities such as Beijing, Shenyang, Chengdu, and Xi'an [5] - From November 14 to November 20, the order volume for respiratory bacterial and viral testing increased by 63%, with a positive detection rate rising to 67.7% [7] Group 3 - Patients are opting for home testing services, with results available online within an average of three hours [8] - Despite the rising demand for medications, online pharmacies and brick-and-mortar stores report that drug supplies are sufficient and supply chains are operating smoothly [10]

Core Viewpoint - Yangtze River Pharmaceutical Group is committed to high-quality and sustainable development by aligning with world-class standards and implementing a comprehensive quality management system across all aspects of its operations [1][2][5]. Group 1: Quality Management Initiatives - The company emphasizes a "big quality" approach, focusing on product lifecycle quality, operational quality, digital application quality, and management quality to enhance overall quality coordination and upgrade [2]. - Yangtze River has established a robust drug quality risk management model, ensuring that all products meet standard requirements through a data-driven, rapid-response safety system [2][4]. - The company has achieved over 180 generic drug varieties that have passed or are deemed equivalent in quality and efficacy evaluations, reinforcing the quality equivalence with original drugs [2]. Group 2: Operational Quality and Culture - Yangtze River promotes a culture of quality through leadership, strategy, personnel, and resource collaboration, establishing clear quality responsibilities and fostering a continuous improvement atmosphere [3]. - The company has implemented over 1,000 quality improvement projects, generating over 500 million yuan in economic benefits and winning 31 international quality management awards [3]. - The annual "Quality Month" activities help instill quality culture among employees, enhancing their sense of ownership and commitment to quality [3]. Group 3: Smart Manufacturing and Digital Transformation - The company leverages digital technologies to enhance production and management processes, achieving data sharing and dynamic analysis for quality decision-making [4]. - Yangtze River's subsidiary, Longfeng Hall, has become the first in Jiangsu Province to pass the national high-tech standardization pilot for intelligent manufacturing in traditional Chinese medicine [4]. - The company aims to be recognized as a top-tier intelligent factory by 2024, reflecting its commitment to improving quality control precision and management efficiency through digital upgrades [4]. Group 4: Sustainable Development and Green Manufacturing - Yangtze River prioritizes green development as a prerequisite for high-quality growth, implementing green manufacturing technologies and practices throughout its operations [12]. - The company has converted wastewater from traditional Chinese medicine production into biogas, generating significant revenue and reducing carbon emissions [11]. - Eight of its factories have been recognized as national green factories, demonstrating the company's commitment to environmental sustainability [12]. Group 5: International Standards and Recognition - Yangtze River has been pursuing the EFQM Global Award since 2012, achieving a five-star rating in 2021 and recently receiving a seven-star certification, which positions the company to compete for the seven-diamond EFQM Global Award [9][10]. - The EFQM model has been integrated into the company's operations, driving improvements across various departments and enhancing overall management capabilities [15]. - The company actively engages in cross-cultural communication training to support its internationalization efforts and ensure compliance with global quality standards [16].

Core Viewpoint - The Jiangsu Brand Construction Conference emphasizes the importance of brand development for Jiangsu enterprises, with a focus on creating globally influential brands, particularly in the pharmaceutical and health sectors [1][3]. Group 1: Brand Development Strategy - The conference theme "Brand Strong Nation, Su Products First" reflects a collective vision for Jiangsu brands to reach a global audience [3]. - Xu Haoyu, representing Yangtze River Pharmaceutical Group, highlighted the company's brand philosophy, which is closely tied to its mission of "seeking progress and protecting lives" [3][5]. - The company prioritizes quality as the cornerstone of brand building, evidenced by its achievements in quality management and international awards [5]. Group 2: Innovation and Market Strategy - Continuous innovation is essential for meeting the growing health demands of the public, alongside maintaining high quality standards [5]. - In 2024, the company introduced a "Health Marketing, Marketing Health" dual strategy, launching health products that align with modern lifestyles [5]. - The company plans to refresh its brand with new products targeting younger demographics, such as "Little Blue Qing Oral Liquid" and "Little Blue Throat Candy" [5][6]. Group 3: Corporate Responsibility and Community Engagement - Xu emphasized that a strong brand is rooted in responsible corporate behavior, which includes providing safe and effective products and engaging in community welfare [8]. - The company has contributed over 1 billion yuan in various charitable efforts and established 80 standardized planting bases to ensure product quality and support local farmers [8]. - The call for collaboration among Jiangsu enterprises aims to enhance the "Su Products" brand and elevate it from regional strength to global recognition [8]. Group 4: Quality and Innovation as Growth Drivers - The conference highlighted the need for Jiangsu to focus on quality, innovation, ecology, culture, and openness to build strong brands that represent Chinese standards [8]. - The establishment of benchmark brands like Yangtze River Pharmaceutical is seen as crucial for contributing to a brand-strong and quality-strong nation [8].